Prostate Cancer
Showing NaN - NaN of 67
Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)
Recruiting
- Prostate Cancer
- talazoparib plus enzalutamide
- Placebo plus enzalutamide
-
Birmingham, Alabama
- +306 more
Jan 18, 2023
Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)
Completed
- Prostate Cancer
- 70.2 Gy 3D-CRT/IMRT
- 79.2 Gy 3D-CRT/IMRT
-
Long Beach, California
- +85 more
Dec 27, 2022
Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE
Recruiting
- Neuroendocrine Tumors
- Prostate Cancer
- Single-Tracer FDG PET/CT Exam
- +3 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Dec 27, 2022
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)
Active, not recruiting
- Prostate Cancer
- abiraterone acetate
- Prednisone
-
Jonesboro, Arkansas
- +204 more
Nov 30, 2022
Breast Cancer, Lung Cancer, Prostate Cancer Trial in Salt Lake City (Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or
Active, not recruiting
- Breast Cancer
- +2 more
- Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus Dietary Supplement (RaproCell)
- +2 more
-
Salt Lake City, UtahOptimal Health Research
Oct 18, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))
Prostate Cancer Trial in Salt Lake City (Rucaparib)
Active, not recruiting
- Prostate Cancer
-
Salt Lake City, UtahHuntsman Cancer Institute
Jun 23, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Prostate Cancer Trial in United States (177Lu-J591, Ketoconazole, Hydrocortisone)
Active, not recruiting
- Prostate Cancer
- 177Lu-J591
- +3 more
-
Los Angeles, California
- +8 more
Mar 25, 2022
Prostate Cancer Trial in United States (Clinical Order Check, Academic Detailing, Audit and Feedback)
Active, not recruiting
- Prostate Cancer
- Clinical Order Check
- +2 more
-
Palo Alto, California
- +10 more
Mar 7, 2022
Prostate Cancer Trial in Canada, United States (Brachytherapy (100/110), Brachytherapy (125/145), External Beam Radiation
Unknown status
- Prostate Cancer
- Brachytherapy (100/110)
- +2 more
-
Phoenix, Arizona
- +169 more
Nov 2, 2021
Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)
Completed
- Metastatic Cancer
- Prostate Cancer
- atrasentan hydrochloride
- +3 more
-
Mobile, Alabama
- +553 more
Oct 8, 2021
Patients With Castration-Resistant Prostate Cancer (CRPC)
Completed
- Prostate Cancer
- +2 more
-
Homewood, Alabama
- +147 more
Mar 2, 2021
Prostate Cancer Trial in Salt Lake City (Radium Ra 223 Dichloride, Enzalutamide)
Completed
- Prostate Cancer
- Radium Ra 223 Dichloride
- Enzalutamide
-
Salt Lake City, UtahHuntsman Cancer Institute
Oct 5, 2020
Prostate Cancer Trial in Canada, United States (bicalutamide, estramustine phosphate sodium, etoposide)
Prostate Cancer Trial in Canada, United States (brachytherapy, iodine I 125, radiation therapy)
Completed
- Prostate Cancer
- brachytherapy
- +2 more
-
Birmingham, Alabama
- +253 more
Oct 21, 2020
Metastatic Cancer, Prostate Cancer Trial in Canada, United States (drug, other, dietary supplement)
Completed
- Metastatic Cancer
- Prostate Cancer
- zoledronic acid
- +5 more
-
Mobile, Alabama
- +240 more
Apr 28, 2020
Prostate Cancer Trial in Canada, United States (3D-CRT)
Completed
- Prostate Cancer
- 3D-CRT
-
Birmingham, Alabama
- +227 more
Jan 8, 2020